一种节的方法来弥补人们对基于QALY的歧视的担忧
1NYU Langone, New York, NY, USA.
概括
经质量调整的寿命年 (QALYs) 面临与残疾和年龄歧视有关的障碍. 一个分布式成本效益分析框架可以通过考虑不平等和效率来解决这些问题.
科学领域:
- 卫生经济学 卫生经济学
- 结果测量结果的测量.
- 卫生政策 卫生政策
背景情况:
- 经质量调整的寿命年 (QALYs) 被广泛使用,但在美国面临重大障碍,特别是关于残疾和年龄歧视.
- 之前试图修改QALY实用功能以解决这些问题的尝试已经被证明很难实施.
- 分布性成本效益分析 (DCEA) 提供了一个框架,将超越纯效率的社会价值观纳入其中.
研究的目的:
- 探索如何利用分布式成本效益分析的框架来克服QALY实施的现有障碍.
- 证明DCEA可以在QALY评估中解决有关残疾和年龄歧视的担忧.
- 提出一种新的方法来改进QALY,使其更加公平和包容.
主要方法:
- 对QALY,公用事业函数和分配成本效益分析现有文献的审查.
- 如何应用DCEA原则来修改QALY计算的概念分析.
- 探索DCEA对解决卫生经济评估中的歧视的影响.
主要成果:
- 该DCEA框架提供了一种方法,在健康经济评估中考虑不平等以及效率.
- 这个框架可以调整以减轻标准QALY计算中固有的残疾和年龄歧视的担忧.
- DCEA提供了一种更为细微的方法来评估健康结果,更好地与社会价值观的公平性保持一致.
结论:
- 分布性成本效益分析为QALY使用中残疾和年龄歧视所带来的挑战提供了一个可行的解决方案.
- 在DCEA框架内调整QALY可以导致更公平,更受社会接受的卫生政策决策.
- 建议对DCEA进行进一步的研究和应用,以提高健康经济评估的公平性.
相关概念视频
01:00Detection of Gross Error: The Q Test
5.6K
When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
5.6K
01:25Strategies for Assessing and Addressing Confounding
83
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
01:17Cochran's Q Test
221
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
221
01:15Assumptions of Survival Analysis
96
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
96
01:24Kaplan-Meier Approach
94
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
94